This report describes the design and estimation procedures to the supplemental Mental Health Surveillance Study data collection to the 2011 National Survey on Drug Use and Health (NSDUH).

This report describes the supplemental Mental Health Surveillance Study data collection to the 2012 National Survey on Drug Use and Health (NSDUH). The MHSS staffing, data collection procedures and materials, data collection staff training, response rates, and quality control procedures.

This report describes the sample design to the 2012 National Survey on Drug Use and Health (NSDUH). A coordinated sample design was developed for the 2005 through 2009 NSDUHs. The 2010-2011 and 2012-2013 samples are extensions of the 5-year sample. This report describes the general sample allocation procedures for the main NSDUH study, the NSDUH\'s Mental Health Surveillance Study, and the Questionnaire Field Test.

This report describes the statistical inference procedures used to produce design-based estimates for the 2012 National Survey on Drug Use and Health (NSDUH). These design-based estimates are presented in the 2012 national findings report detailed tables, as well as the 2012 mental health findings report and detailed tables. The report covers missingness rates, sampling error, degrees of freedom, statistical significance differences, confidence intervals, incidence estimates, and suppression of estimates with low precision.

Learn about the sample design used for the 2023 National Survey on Drug Use and Health (NSDUH). The report describes the five stages of sample selection, sample weighting and variance estimation procedures, and the Mental Illness Calibration Study sample design.Chapters:Introduces the report, describes the target population, and provides a general overview of the 2023 NSDUH sample design.Summarizes the 2014 through 2023 coordinated sample design.Discusses the first three stages of selection in greater detail.Describes the 2023 NSDUH hybrid field enumeration and address-based sampling frame.Discusses the fourth and fifth stages of selection.Describes sample weighting and variance estimation procedures for 2023.Summarizes the sample design for the Mental Illness Calibration Study.

This report describes the supplemental Mental Health Surveillance Study data collection to the 2011 National Survey on Drug Use and Health (NSDUH).

The Mental Health Surveillance Study (MHSS) clinical follow-up was conducted as part of the National Survey on Drug Use and Health (NSDUH) from 2008 to 2012 for the primary purpose of developing models that estimate the prevalence of serious mental illness (SMI) and any mental illness (AMI) in the adult (18 or older) U.S. population (Center for Behavioral Health Statistics and Quality [CBHSQ], 2014). In each of these years, the MHSS clinical study consisted of a subsample of eligible adults selected from the main NSDUH study for follow-up clinical interviews. A prediction model was developed that included SMI status (collected in the clinical interview) as the dependent variable. The predictor variables were variables such as psychological distress and impairment measures that were collected in the main NSDUH questionnaire for adults. The resulting prediction model developed from the MHSS clinical data was then applied to all adult NSDUH respondents to obtain the predicted probability of SMI for each respondent.

This report summarizes the 2018 NSDUH methods and other supporting information relevant to estimates of substance use and mental health issues, and organized into five chapters. Chapter 1 is an introduction to the report. Chapter 2 describes the survey, including information about the sample design; data collection procedures; and key aspects of data processing, such as development of analysis weights. Chapter 3 presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures. Chapter 4 covers special topics related to prescription psychotherapeutic drugs. Chapter 5 describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population. Appendix A is a glossary that covers key definitions for use as a resource with the 2018 NSDUH reports and detailed tables. Appendix B provides a list of contributors to the report.

Use this summary report to properly interpret 2022 NSDUH estimates related to substance use, mental health, and treatment. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2022 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into five chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures and questionnaire changes, and key aspects of data processing such as development of the analysis weights.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, revised estimates for 2021 to account for data collection mode, and issues around selected substance use and mental health measures.Special topics related to prescription psychotherapeutic drugs.Description of other sources of data on substance use and mental health issues in the United States, including data sources for populations outside the NSDUH target population.An appendix covers key definitions used in NSDUH reports and tables.

This report describes the statistical inference procedures used to produce design-based estimates for the 2011 National Survey on Drug Use and Health (NSDUH). These design-based estimates are presented in the 2011 national findings report detailed tables, as well as the 2011 mental health findings report and detailed tables.